Oxford-based AI-driven drug discovery company.
| Date | Round | Amount |
|---|---|---|
| Dec 2020 | Grant Exscientia received a $4.2M grant from the Bill & Melinda Gates Foundation to apply its AI platforms to drug discovery for infectious diseases and family planning. | $4.2M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.